• Protease Inhibitor Cocktail EDTA-Free: Precision in Phosphor

  2026-08-04

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO delivers uncompromised protease inhibition without interfering with phosphorylation-sensitive studies. Its compatibility with advanced signaling assays and robust prevention of protein degradation set a new benchmark for high-fidelity protein extraction workflows.

• Thermal-Protective Hydrogel Enables Curative Chemo-Immunomod

  2026-08-03

  This study introduces an injectable, dual-responsive hydrogel that combines thermal protection with programmed delivery of mitoxantrone and Resiquimod (R-848), addressing both safety and immune resistance during tumor ablation. The findings suggest a material-driven approach to improving ablation efficacy and reducing recurrence by integrating chemo-immunomodulation and innate immune response activation.

• Catalpol’s Protective Mechanisms in Cardio-Cerebrovascular D

  2026-08-03

  This comprehensive review synthesizes recent evidence on catalpol, an iridoid glucoside, highlighting its multifaceted protective effects against major cardio-cerebrovascular diseases (CVDs). The paper details catalpol’s antioxidant, anti-inflammatory, and antiapoptotic actions, and explores key molecular pathways relevant to the prevention and treatment of CVDs.

• Applied Workflows Using (S)-1-(3-fluoro-4-(trifluoromethoxy)

  2026-08-02

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) enables precise modulation of the sEH-Nrf2 pathway in osteoporosis and redox signaling research. With high solubility and validated purity, this APExBIO compound empowers reproducible, advanced enzyme inhibition and signaling studies beyond standard small molecule tools.

• Safe DNA Gel Stain: Safer, Sensitive DNA and RNA Visualizati

  2026-08-01

  Safe DNA Gel Stain offers a sensitive, less mutagenic alternative for DNA and RNA gel staining in molecular biology. Its blue-light and UV compatibility supports improved safety and cloning workflows while minimizing DNA damage compared to ethidium bromide.

• Epacadostat (INCB024360): IDO1 Inhibition in Immuno-Oncology

  2026-07-31

  Epacadostat (INCB024360) is a potent, selective oral IDO1 inhibitor with nanomolar IC50, widely used in immuno-oncology research. Its mechanism blocks kynurenine pathway-mediated immune evasion, supporting T lymphocyte proliferation. Preclinical benchmarks demonstrate dose-dependent tumor growth inhibition in IDO1-expressing models.

• Fosinopril Sodium: Pharmacokinetic Innovation for Advanced H

  2026-07-31

  Explore how Fosinopril sodium, a potent ACE inhibitor, enables nuanced hypertension research by leveraging its unique dual elimination and phosphinic acid chemistry. This article reveals protocol-critical insights and practical guidance for cardiovascular and renal disease models.

• Pepstatin A: Unraveling Aspartic Protease Inhibition in Tran

  2026-07-30

  This article provides translational researchers with an integrated mechanistic and strategic perspective on Pepstatin A, an ultra-pure aspartic protease inhibitor from APExBIO. By synthesizing recent advances—including macrophage infection mechanisms in COVID-19—and pragmatic protocol guidance, we chart a path from molecular insight to experimental and clinical innovation. Unique to this piece is its cross-domain analysis bridging viral pathogenesis, osteoclast differentiation, and immune modulation, grounded in contemporary evidence and the evolving competitive landscape.

• SB 202190: Precision p38 MAP Kinase Inhibitor Workflows

  2026-07-30

  SB 202190 empowers researchers to dissect p38 MAP kinase signaling with nanomolar precision, fueling breakthroughs across inflammation, cancer therapeutics, and neuroprotection. This guide details optimized workflows, key troubleshooting steps, and practical insights bridging organoid models to in vivo disease studies.

• Demethyleneberberine Inhibits NF-κB/MAPK to Alleviate Autoim

  2026-07-29

  The reference study establishes Demethyleneberberine (DMB) as a potent suppressor of autoimmune hepatitis in mice, acting through targeted inhibition of NF-κB and MAPK signaling. These mechanistic insights provide a strong foundation for using DMB as a research tool in inflammation-driven liver disease models.

• Arrb2-Induced M2 Macrophage Polarization Mitigates Hepatic I

  2026-07-29

  This study reveals that hepatocyte-specific Arrb2 expression drives M2 macrophage polarization, leading to reduced hepatic ischemia–reperfusion injury (IRI) by upregulating the metabolite 6-ketoLCA. These findings clarify hepatocyte–macrophage crosstalk and suggest new strategies for refining IRI models and improving liver transplant outcomes.

• Quantifying Pesticide Drift: UAV vs. Knapsack Sprayers with

  2026-07-28

  This study rigorously compares pesticide spray drift from unmanned aerial vehicles (UAVs) and electric knapsack sprayers (EKS) using Rhodamine B as a fluorescent tracer. The findings demonstrate that UAV applications result in significantly greater drift distances and higher deposition rates than EKS, providing pivotal data for environmental risk assessments and regulatory guidance.

• Ceftazidime in Multidrug Resistance: Mechanisms, Limits & In

  2026-07-28

  Explore the scientific depth of ceftazidime, a third-generation cephalosporin, in the context of multidrug-resistant Gram-negative infections. This article reveals pivotal innovations in resistance mechanisms and practical assay guidance that set it apart from existing coverage.

• AP20187: Chemical Inducer of Dimerization for Precision Gene

  2026-07-27

  AP20187 distinguishes itself as a cell-permeable chemical inducer of dimerization, enabling tightly regulated gene and protein activation in experimental and therapeutic systems. Its high solubility, validated in vivo efficacy, and proven role in advanced signaling workflows make it an indispensable tool for translational research and regulated cell therapy.

• Capsazepine in Advanced TRPV1 Pain and Apoptosis Research

  2026-07-27

  Explore how Capsazepine, a potent TRPV1 ion channel antagonist, enables next-generation pain and apoptosis research. This article offers a deep scientific perspective on its mechanisms and unique research applications beyond standard protocols.

450 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page